COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 580: Articles 5791-5800  | Next

Biophysical characterisation of the structure of a SARS-CoV-2 self-amplifying - RNA (saRNA) vaccine
Myatt, D. P., Wharram, L., Graham, C., Liddell, J., Branton, H., Pizzey, C., Cowieson, N., Rambo, R., Shattock, R.
10.1101/2022.10.03.507132 — Posted: 2022-10-03
Reduction in circulating monocytes correlates with persistent post-COVID pulmonary fibrosis in multi-omic comparison of long-haul COVID and IPF
Bingham, G. C., Muehling, L. M., Li, C., Huang, Y., Abebayehu, D., Noth, I., Sun, J., Woodfolk, J. A., Barker, T. H., Bonham, C.
10.1101/2022.09.30.22280468 — Posted: 2022-10-02
COVID treatment and in-hospital length of stay inequalities between race in the US over time
Althouse, B. M., Baker, C., Smits, P. D., Gratzl, S., Lee, R. H., Cartwright, B. M. G., Siminov, M., Wang, M. D., Stucky, N.
10.1101/2022.09.30.22280586 — Posted: 2022-10-01
COVID-19 vaccine antibody response is associated with side-effects, chronic health conditions, and vaccine type in a large Northern California cohort
Solomon, O., Adams, C., Horton, M., Wong, M. P., Meas, M., Shao, X., Fedrigo, I., Hernandez, S., Quach, H. L., Quach, D. L., Barcellos, A. L., Coloma, J., Busch, M. P., Harris, E., Barcellos, L. F.
10.1101/2022.09.30.22280166 — Posted: 2022-10-01
Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Tseng, H. F., Ackerson, B. K., Bruxvoort, K. J., Sy, L. S., Tubert, J. E., Lee, G. S., Ku, J. H., Florea, A., Luo, Y., Qiu, S., Choi, S. K., Takhar, H. S., Aragones, M., Paila, Y. D., Chavers, S., Qian, L.
10.1101/2022.09.30.22280573 — Posted: 2022-10-01
Is there a role for RDTs as we live with COVID? An assessment of different strategies
Bonnet, G., Vassall, A., Jit, M.
10.1101/2022.09.30.22280569 — Posted: 2022-10-01
Tixagevimab-cilgavimab as an early treatment for COVID-19 in kidney transplant recipients
Benotmane, I., Olagne, J., Gautier-Vargas, G., Cognard, N., Heibel, F., Braun-Parvez, L., Keller, N., Martzloff, J., Perrin, P., Pszczolinski, R., Moulin, B., Fafi-Kremer, S., Caillard, S.
10.1101/2022.09.30.22280568 — Posted: 2022-10-01
Covid-19: Qualitative Change in the Behavior of the "Virus vs Human" System - From Limit Cycle to Sustained Focus
Sokolov, A.
10.1101/2022.09.28.22280472 — Posted: 2022-09-30
Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
Mahalingam, G., Arjunan, P., Periasami, Y., Dhyani, A. K., Devaraju, N., Rajendiran, V., Christopher, A. C., KT, R. D., Darasingh, I., Thangavel, S., Murugesan, M., Moorthy, M., Srivastava, A., Marepally, S.
10.1101/2022.09.30.510287 — Posted: 2022-09-30
The SARS-CoV-2 mutation landscape is shaped before replication starts
Masone, D., Alvarez, M. S., Polo, L. M.
10.1101/2022.09.29.510149 — Posted: 2022-09-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).